EVM
ABMD

Eaton Vance Management’s Abiomed Inc ABMD Stock Holding History

Eaton Vance Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$31.1M Buy
126,759
+143
+0.1% +$38.6K 0.05% 354
2022
Q2 		$31.3M Sell
126,616
-925
-0.7% -$250K 0.04% 363
2022
Q1 		$42.2M Buy
127,541
+9,741
+8% +$3M 0.05% 344
2021
Q4 		$42.3M Buy
117,800
+28
+0% +$9.46K 0.05% 329
2021
Q3 		$38.1M Buy
117,772
+8,189
+7% +$2.77M 0.05% 317
2021
Q2 		$34.2M Buy
109,583
+568
+0.5% +$174K 0.05% 349
2021
Q1 		$34.7M Buy
109,015
+12,927
+13% +$4.14M 0.05% 332
2020
Q4 		$31.2M Sell
96,088
-24,379
-20% -$6.74M 0.05% 339
2020
Q3 		$33.4M Buy
120,467
+7,986
+7% +$2.3M 0.06% 274
2020
Q2 		$27.2M Buy
112,481
+21
+0% +$4.22K 0.06% 290
2020
Q1 		$16.3M Buy
112,460
+23,795
+27% +$3.95M 0.04% 324
2019
Q4 		$15.1M Buy
88,665
+13
+0% +$2.41K 0.03% 379
2019
Q3 		$15.8M Buy
88,652
+7,652
+9% +$1.65M 0.03% 353
2019
Q2 		$21.1M Buy
81,000
+76
+0.1% +$20.2K 0.05% 299
2019
Q1 		$23.1M Buy
80,924
+2,244
+3% +$746K 0.05% 271
2018
Q4 		$25.6M Buy
78,680
+18,750
+31% +$6.51M 0.07% 242
2018
Q3 		$27M Hold
59,930
– – 0.06% 250
2018
Q2 		$24.5M Sell
59,930
-46,248
-44% -$16.8M 0.06% 256
2018
Q1 		$30.9M Buy
106,178
+56,545
+114% +$14.3M 0.04% 312
2017
Q4 		$9.3M Buy
49,633
+5,262
+12% +$982K 0.02% 399
2017
Q3 		$7.48M Buy
44,371
+22,235
+100% +$3.36M 0.02% 419
2017
Q2 		$3.17M Buy
22,136
+13,746
+164% +$1.85M 0.01% 574
2017
Q1 		$1.05M Hold
8,390
– – ﹤0.01% 767
2016
Q4 		$945K Buy
+8,390
New +$972K ﹤0.01% 738

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Eaton Vance Management's ABMD Position: Q3 2022 in Review

Eaton Vance Management increased its Abiomed Inc (ABMD) stake by 0.11% in Q3 2022, buying an estimated $38.6K and bringing the position to 126,759 shares worth $31.1M. The position accounts for 0.05% of the portfolio, ranked #354.

Eaton Vance Management first reported a position in ABMD in Q4 2016 and has held it in 24 quarters since. The position peaked at $42.3M in Q4 2021. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Eaton Vance Management held 126,759 shares of Abiomed Inc worth $31.1M as of Q3 2022.
  • Eaton Vance Management bought 143 Abiomed Inc shares in Q3 2022, an estimated $38.6K.
  • Abiomed Inc made up 0.05% of Eaton Vance Management's portfolio in Q3 2022, its #354 holding.
  • Eaton Vance Management first reported a position in Abiomed Inc in Q4 2016 and has held it in 24 quarters since.
  • Eaton Vance Management's Abiomed Inc position peaked at $42.3M in Q4 2021.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.